Medroxyprogesterone Acetate Injection, Suspension, Extended Release
Product Images NDC 0548-5400

8 FDA label images from Amphastar Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Medroxyprogesterone Acetate (NDC 0548-5400). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amphastar Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
A logarithmic scale chart titled 'Risk estimates for breast cancer in DMPA users' showing odds ratios with 95% confidence intervals from various studies (Lee et al. 1987, Paul et al. 1989, WHO 1991, Shapiro et al. 2000, Li et al. 2012). It compares breast cancer risk associated with medroxyprogesterone acetate (DMPA) use, illustrating point estimates and confidence intervals relative to an odds ratio of 1, where values greater than 1 indicate increased risk.*
FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)
Chemical structure of Medroxyprogesterone acetate, showing its steroid backbone with characteristic functional groups including ketones and acetyl groups.*
FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
An instructional illustration showing a hand using a twisting motion to remove or attach a cap from a syringe or injection vial. The diagram likely demonstrates part of the preparation process for administering Medroxyprogesterone Acetate injection suspension.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
An instructional illustration showing a hand holding a syringe, preparing to administer an injection. The image is labeled as Figure 2 and demonstrates the proper grip and technique for using the syringe.*
FDA Label Image

Chart (Chart)

Chart (Chart)
A vertical arrow chart illustrating pregnancy rates per 100 women in one year relative to birth control methods. The chart categorizes methods from fewer pregnancies (implants, injections, intrauterine devices, sterilization) to more pregnancies (no birth control), with intermediate categories including birth control pills, skin patches, vaginal rings, condoms, diaphragms, and behavior-based methods.*
FDA Label Image

Carton-stock-5400 (Carton Stock 5400)

Carton-stock-5400 (Carton Stock 5400)
Medroxyprogesterone Acetate Injectable Suspension, USP 150 mg/mL carton label for 1 mL single-dose vial. The label indicates Rx only, for intramuscular use only, and includes detailed ingredient information and storage instructions. Manufactured by Amphastar Pharmaceuticals, Inc., Rancho Cucamonga, CA.*
FDA Label Image

Carton-stock 5401-25-pack (25pack Carton)

Carton-stock 5401-25-pack (25pack Carton)
Packaging label for Medroxyprogesterone Acetate Injection, Suspension, Extended Release, 150 mg/mL. The label includes product name, strength, and dosage form along with packaging information showing 25 x 1 mL single-dose vials. Labeler Amphastar Pharmaceuticals, Inc. is specified. The image shows the carton layout for this prescription drug product.*
FDA Label Image

Container-stock-5701 (Container Stock 5701)

Container-stock-5701 (Container Stock 5701)
Packaging label for Medroxyprogesterone Acetate Injectable Suspension, USP, 150 mg/mL, for intramuscular use only. The label indicates the product is an extended-release injection by Amphastar Pharmaceuticals, Inc., Rancho Cucamonga, CA. It includes storage instructions, dosage form, route, assembly instructions for use, and ingredients details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.